Diagnostic Testing

There’s no doubt that we have entered an era when important opportunities will exist to delay or diminish the symptoms of dementia. As we’ve been covering in agebuzz, there is now a new drug (Leqembi) available to delay impairment and decline in patients with mild cognitive impairment or the early…

If you or a loved one suffers from mild cognitive impairment or have been diagnosed with early Alzheimer’s Disease, you’ve likely followed the news over the last few months about a new treatment awaiting FDA approval. Well, that FDA approval has arrived: Leqembi, a medication that targets the amyloid plaques…

Despite being classified as one of the 4 most dangerous health issues facing us today, and despite the fact that each year, 2 million broken bones are attributable to it, there’s still a lot of mystery and misunderstanding among older adults about osteoporosis. In fact, in a recent study of…

With so many hearing aid options and devices now available, it’s hard to imagine that anyone who has hearing difficulties has not yet found help. However, that would assume that you know you have hearing problems, have the money to purchase hearing aids, and/or are desirous to do something about…

For the more than 6 million Americans currently thought to have Alzheimer’s, and their loved ones, the possible benefits of new medications can’t come soon enough. As the most common cause of dementia, Alzheimer’s Disease predominantly afflicts older women (⅔ of Alzheimer’s patients are female) and almost ¾ of those…

That dreaded “D” Word: dementia. No one looks forward to receiving a dementia diagnosis or being told they are at risk for dementia. But we have reached a point in our understanding of the disease, and our diagnostic capabilities, that we can now predict with some certainty, and at a…